Michael Leapman
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Diagnosis and Treatment 80
- Prostate Cancer Treatment and Research 31
- Renal cell carcinoma treatment 9
- Surgery 19
- Bladder and Urothelial Cancer Treatments 9
- Co-authors
- Matthew R. Cooperberg (28 shared papers)Cary P. Gross (41 shared papers)Preston C. Sprenkle (35 shared papers)Jamil Syed (15 shared papers)Paweł Rajwa (18 shared papers)Kevin A. Nguyen (14 shared papers)Jonathan Brajtbord (1 shared paper)Walter Hsiang (18 shared papers)
- Journals
- The Journal of Urology (27 papers)Urology (16 papers)Journal of Clinical Oncology (14 papers)Urologic Oncology Seminars and Original Investigations (12 papers)JAMA Network Open (9 papers)
- Partner nations
- United StatesPolandAustria
In The Last Decade
Michael Leapman
170 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 145
- Pulmonary and Respiratory Medicine 874
- Cancer Research 106
- Oncology 180
- Urology 35
- Radiology, Nuclear Medicine and Imaging 104
Countries citing papers authored by Michael Leapman
This map shows the geographic impact of Michael Leapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Leapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Leapman more than expected).
Fields of papers citing papers by Michael Leapman
This network shows the impact of papers produced by Michael Leapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Leapman. The network helps show where Michael Leapman may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Leapman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 75 | |
| 2 | 2021 | 73 | |
| 3 | 2018 | 73 | |
| 4 | 2021 | 67 | |
| 5 | 2020 | 61 | |
| 6 | 2019 | 60 | |
| 7 | 2021 | 59 | |
| 8 | 2024 | 44 | |
| 9 | 2022 | 40 | |
| 10 | 2013 | 37 | |
| 11 | 2022 | 36 | |
| 12 | 2022 | 36 | |
| 13 | 2016 | 35 | |
| 14 | 2023 | 35 | |
| 15 | 2019 | 32 | |
| 16 | 2021 | 32 | |
| 17 | 2020 | 31 | |
| 18 | 2014 | 30 | |
| 19 | 2013 | 29 | |
| 20 | 2017 | 25 |
About Michael Leapman
Michael Leapman is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Public Health, Environmental and Occupational Health and Economics and Econometrics, having authored 194 papers that have together received 1.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (80 papers), Prostate Cancer Treatment and Research (31 papers), Renal cell carcinoma treatment (9 papers), Bladder and Urothelial Cancer Treatments (9 papers), Economic and Financial Impacts of Cancer (8 papers), Climate Change and Health Impacts (7 papers), Cancer, Lipids, and Metabolism (5 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (874 citations), Cancer Research (106 citations), Oncology (180 citations), Urology (35 citations) and Radiology, Nuclear Medicine and Imaging (104 citations). Michael Leapman has collaborated with scholars based in United States, Poland and Austria. Frequent co-authors include Matthew R. Cooperberg, Cary P. Gross, Preston C. Sprenkle, Jamil Syed, Paweł Rajwa, Kevin A. Nguyen, Jonathan Brajtbord, Walter Hsiang, Xiaomei Ma and Peter R. Carroll. Their work appears in journals such as The Journal of Urology, Urology, Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.